Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Jan 2026 highlights: Astra, CSPC sign up to US$ 18.5 bn obesity deal; Wegovy’s pill version debuts in US

    Stock Recap
    #PipelineProspector

    Menu

    CEFAZOLIN AND DEXTROSE

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 139Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    27/02/2026 ACS DOBFAR SPA
    Italy
    		 Sungjin Exim Co., Ltd. 20210427-210-J-635 Cefazolin sodium 2021-04-27 ACS Dobfar SpA Italy Viale Addetta, 2a/12-3/5 20067 Tribiano, Milano, Italy
    27/02/2026 CSPC Pharmaceutical Group
    China
    		 Daeshin Pharmaceutical Co., Ltd. 20201012-211-J-478(1) Cefazolin sodium 2021-05-14 CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co.,Ltd. China No.88 Yangzi Road, Economic&Technological Development Zone, Shijiazhuang City, Hebei Province
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.